Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-23

FDA Approved: VALCHLOR — Original Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

FDA approved VALCHLOR (mechlorethamine hydrochloride) gel in an original application for the treatment of mycosis fungoides, a type of cutaneous T-cell lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valchlor (mechlorethamine)

Snippet

ORIG AP for VALCHLOR (MECHLORETHAMINE HYDROCHLORIDE)